アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/04/08 | 1,610 | 1,610.5 | 1,590.5 | 1,596.5 | -6 | -0.4% | 5,212,600 |
2024/04/05 | 1,598 | 1,607 | 1,582.5 | 1,602.5 | -1 | -0.1% | 8,254,600 |
2024/04/04 | 1,628.5 | 1,631 | 1,603 | 1,603.5 | -17.5 | -1.1% | 7,907,800 |
2024/04/03 | 1,646 | 1,647 | 1,613.5 | 1,621 | -27.5 | -1.7% | 7,124,300 |
2024/04/02 | 1,638 | 1,652.5 | 1,634.5 | 1,648.5 | +7.5 | +0.5% | 6,014,900 |
2024/04/01 | 1,652 | 1,671 | 1,640.5 | 1,641 | -2.5 | -0.2% | 6,093,200 |
2024/03/29 | 1,638.5 | 1,663 | 1,635.5 | 1,643.5 | +18.5 | +1.1% | 8,612,400 |
2024/03/28 | 1,655 | 1,659.5 | 1,622 | 1,625 | -67.5 | -4% | 9,670,000 |
2024/03/27 | 1,685 | 1,696.5 | 1,677 | 1,692.5 | +18 | +1.1% | 12,397,500 |
2024/03/26 | 1,650 | 1,679.5 | 1,642 | 1,674.5 | +21 | +1.3% | 8,019,600 |
2024/03/25 | 1,676 | 1,676 | 1,653.5 | 1,653.5 | -18.5 | -1.1% | 7,191,500 |
2024/03/22 | 1,669 | 1,684 | 1,651.5 | 1,672 | -5 | -0.3% | 10,452,200 |
2024/03/21 | 1,661 | 1,679 | 1,653 | 1,677 | +30.5 | +1.9% | 10,254,800 |
2024/03/19 | 1,636.5 | 1,646.5 | 1,630 | 1,646.5 | +10.5 | +0.6% | 5,013,800 |
2024/03/18 | 1,626 | 1,642 | 1,622 | 1,636 | +21 | +1.3% | 6,715,400 |
2024/03/15 | 1,600 | 1,615.5 | 1,596 | 1,615 | +22 | +1.4% | 8,037,300 |
2024/03/14 | 1,584 | 1,600.5 | 1,578.5 | 1,593 | +9.5 | +0.6% | 5,628,000 |
2024/03/13 | 1,594 | 1,597 | 1,583.5 | 1,583.5 | -11 | -0.7% | 7,033,900 |
2024/03/12 | 1,610.5 | 1,610.5 | 1,573 | 1,594.5 | -3.5 | -0.2% | 6,782,500 |
2024/03/11 | 1,577 | 1,603 | 1,573.5 | 1,598 | +22.5 | +1.4% | 10,667,900 |
2024/03/08 | 1,567.5 | 1,581.5 | 1,551 | 1,575.5 | -23.5 | -1.5% | 18,824,400 |
2024/03/07 | 1,624.5 | 1,630.5 | 1,596 | 1,599 | -37.5 | -2.3% | 17,418,900 |
2024/03/06 | 1,636 | 1,650 | 1,626 | 1,636.5 | +0.5 | ±0% | 9,089,400 |
2024/03/05 | 1,662 | 1,670 | 1,635.5 | 1,636 | -45.5 | -2.7% | 11,389,100 |
2024/03/04 | 1,686 | 1,687 | 1,663 | 1,681.5 | +7 | +0.4% | 8,117,400 |
2024/03/01 | 1,656 | 1,679.5 | 1,655 | 1,674.5 | +23 | +1.4% | 7,094,100 |
2024/02/29 | 1,658.5 | 1,666 | 1,638.5 | 1,651.5 | -12.5 | -0.8% | 8,823,500 |
2024/02/28 | 1,665.5 | 1,674.5 | 1,658.5 | 1,664 | +5.5 | +0.3% | 5,539,400 |
2024/02/27 | 1,640 | 1,660 | 1,637 | 1,658.5 | -13 | -0.8% | 10,490,900 |
2024/02/26 | 1,655 | 1,678.5 | 1,649 | 1,671.5 | +22 | +1.3% | 9,134,600 |
2024/02/22 | 1,671 | 1,672.5 | 1,647.5 | 1,649.5 | -27.5 | -1.6% | 11,540,500 |
2024/02/21 | 1,688.5 | 1,691 | 1,675.5 | 1,677 | -8 | -0.5% | 5,663,400 |
2024/02/20 | 1,690 | 1,695.5 | 1,680.5 | 1,685 | +2.5 | +0.1% | 5,214,100 |
2024/02/19 | 1,678.5 | 1,690 | 1,670 | 1,682.5 | +7.5 | +0.4% | 5,396,400 |
2024/02/16 | 1,665 | 1,682 | 1,653 | 1,675 | +22.5 | +1.4% | 7,595,500 |
2024/02/15 | 1,670 | 1,670 | 1,639 | 1,652.5 | -13.5 | -0.8% | 5,805,600 |
2024/02/14 | 1,661.5 | 1,669.5 | 1,646.5 | 1,666 | +11 | +0.7% | 7,484,700 |
2024/02/13 | 1,623 | 1,655 | 1,618 | 1,655 | +39.5 | +2.4% | 10,742,300 |
2024/02/09 | 1,597 | 1,621.5 | 1,594 | 1,615.5 | +5.5 | +0.3% | 9,391,000 |
2024/02/08 | 1,610 | 1,619.5 | 1,591 | 1,610 | -11.5 | -0.7% | 15,869,200 |
2024/02/07 | 1,606 | 1,629 | 1,605 | 1,621.5 | -1.5 | -0.1% | 11,396,000 |
2024/02/06 | 1,662 | 1,699.5 | 1,623 | 1,623 | -77 | -4.5% | 24,370,600 |
2024/02/05 | 1,680 | 1,703 | 1,668 | 1,700 | +20 | +1.2% | 9,320,200 |
2024/02/02 | 1,699.5 | 1,703 | 1,680 | 1,680 | -12 | -0.7% | 7,148,500 |
2024/02/01 | 1,705 | 1,712.5 | 1,680.5 | 1,692 | -33 | -1.9% | 9,933,200 |
2024/01/31 | 1,711 | 1,729.5 | 1,706 | 1,725 | +12 | +0.7% | 6,895,500 |
2024/01/30 | 1,714 | 1,730.5 | 1,713 | 1,713 | +0.5 | ±0% | 4,680,300 |
2024/01/29 | 1,698 | 1,721.5 | 1,698 | 1,712.5 | +24.5 | +1.5% | 6,089,500 |
2024/01/26 | 1,693.5 | 1,695 | 1,676 | 1,688 | -13 | -0.8% | 7,662,700 |
2024/01/25 | 1,700 | 1,707.5 | 1,682.5 | 1,701 | -2 | -0.1% | 8,092,400 |
201~
250
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム